To screen or not to screen: Is that really the question?

Annals of Internal Medicine

Volumn 145, Issue 11, 2006, Pages 857-859

  Branson, Bernard M ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIAGNOSTIC TEST; EDITORIAL; HEALTH CARE FACILITY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MASS SCREENING; PATIENT COUNSELING; PRENATAL SCREENING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; VIRUS LOAD; VIRUS TRANSMISSION; ADULT; COST BENEFIT ANALYSIS; ECONOMICS; METHODOLOGY; NOTE; UNITED STATES;

ADULT; COST-BENEFIT ANALYSIS; HIV INFECTIONS; HUMANS; MASS SCREENING; UNITED STATES;

EID: 36048935727     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-145-11-200612050-00011     Document Type: Editorial

References (20)